Sei Investments CO Roivant Sciences Ltd. Transaction History
Sei Investments CO
- $66.7 Billion
- Q1 2024
A detailed history of Sei Investments CO transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Sei Investments CO holds 13,484 shares of ROIV stock, worth $142,391. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,484
Previous 18,869
28.54%
Holding current value
$142,391
Previous $211,000
32.7%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
263Shares Held
489MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$771 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$733 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$705 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$382 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$376 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.44B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...